期刊文献+

度洛西汀与帕罗西汀治疗老年期抑郁症临床对照研究 被引量:5

Controlled Study of Duloxetine and Paroxitine in Treatment of Patients with Senile Depression
下载PDF
导出
摘要 目的:比较度洛西汀与帕罗西汀治疗老年期抑郁症的疗效及安全性。方法:将60例老年期抑郁症患者随机分为度洛西汀组与帕罗西汀组,疗程8周,采用汉密尔顿抑郁量表(HAMD)评定临床疗效,副反应量表(TESS)评定不良反应。结果:度洛西汀组与帕罗西汀组总体疗效相当,度洛西汀起效较快,两组不良反应均较轻。结论:度洛西汀与帕罗西汀都是治疗老年期抑郁症较理想的药物,与帕罗西汀相比,度洛西汀治疗伴有躯体症状的抑郁症患者疗效更好。 Objective:To compare the efficacy and safety of duloxetine and paroxitine in the treatment of patients with senile depression.Method:60 patients with senile depression were divided into two groups who treatment with duloxetine or paroxitine for eight weeks.The efficacy was evaluated by Hamilton depressive scale(HAMD),safety was evaluated by treatment emergant symptom scale(TESS).Result:The efficacies of duloxetine and paroxitine in treatment of patients with senile depression were similar.They had no significant differences between two groups,Both of them took effect more quickly and their side effects were less and mild.Conclusion:It suggests that both duloxetine and paroxitine might be recommended as appropriated drugs in the treatment of senile depression.Du loxetine shows better efficacy than parox itine in the patients with somatic symptoms1.
作者 赵芳全
出处 《中国医学创新》 CAS 2012年第28期31-32,共2页 Medical Innovation of China
关键词 老年期抑郁症 度洛西汀 帕罗西汀 Senile depression Duloxetine Paroxitine
  • 相关文献

参考文献5

  • 1Costa E, Silvs J.Randomized, double-blind comparison of venla faxine and fluoxetine in outpatients with major depression[J].Jclin Psychiatry, 1998, 59(1):352.
  • 2李冰,王祖新.万拉法新治疗抑郁症的临床验证[J].上海精神医学,1997,9(4):269-272. 被引量:67
  • 3Rabassedax.Duloxetine:a new semton in norad renalin ereup take inhibitor for the treatment of depression[J].Drugs Today, 2004, 40(1):773-790.
  • 4王岳鸿,张晓友,宋铁兵,李士峰,王浩.盐酸度洛西汀临床研究近况[J].黑龙江医药科学,2007,30(6):39-40. 被引量:23
  • 5Michael J, Detkea M D, Yili L, et al.Duloxetine 60 mg once daily dosing verbus placebo in the acute treatment of major depression[J].J Psychiatric Res, 2003, 40(1):383-390.

二级参考文献6

  • 1Danuser H, Bemis K,Thor KB. Pharmacological analysis of the noradrenergic control of central sympathetic and somatic reflexes controlling the lower urinary tract in the anesthetized cat[J]. J Pharmacol Exp Ther, 1995,274 (2) : 820 - 825
  • 2Xavier, Rabasseda. Duloxetine - anewserotonin/noradrenalinere - up take in hibitor for the treatment of depression [J]. Drugs Today (Barc) ,2004. 40(9) : 773 - 908
  • 3RobertMA, Hirsehfeld, LanaA. et al. Newer antidepressants: views of effieaey and safety of eseital opramand duloxetine[J]. J Clin. Psychiatry,2004,65 (suppl4):46 -52
  • 4Detke MJ ,Lu Y, Goldstein DJ, et al. Demitrack MA Duloxetine, 60mg once daily, for major depressive disorder: a randomized double - blind placebo - controlled trial [J]. Clin Psychiatry, 2002,63 (4) : 308
  • 5Goldstein DJ,Lu Y,Detke MJ,et al. Duloxetine in the treatment of depressiona double - blind placebo- controlled comparison with paroxetine [J]. J Clin Psycbopbarmacol, 2004,24 (4) : 389 - 399
  • 6Mallinckrodt CH, Goldstein D J, Detke MJ, et al Duloxetine ; A new treatment for the emotional and physical symptoms of depression[J], Prim Care Companion J Clin Psychiatry, 2003,5 (1):19-20

共引文献87

同被引文献65

  • 1喻东山.强迫症的药物治疗进展[J].中国全科医学,2009,12(8):663-665. 被引量:13
  • 2王贵山,王冠中,王爱芹,叶萌,张传芝.万拉法新与氯米帕明治疗难治性强迫症的对照研究[J].中国行为医学科学,2004,13(4):405-406. 被引量:11
  • 3周云飞,张亚林.难治性强迫症研究进展[J].中国神经精神疾病杂志,2004,30(6):477-478. 被引量:26
  • 4喻东山.强迫症治疗的新进展[J].中华精神科杂志,2005,38(1):50-52. 被引量:65
  • 5世界卫生组织.ICD-10精神与行为障碍分类[M∥范晓东,汪向东,于欣,等,译.北京:人民卫生出版社,1993:116-118.
  • 6Goodman W K, Price L H, Rasmussen S A, et al.The Yale-Brown Obsessive Compulsive Scale: Development use and reliability[J].Arch Gen Psychiatry, 1989, 46 ( 11 ) : 1006-1011.
  • 7Pessina E, Albert U, Bogetto F, et al.Aripiprazole augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive- compulsive disorder: a 12-week open-label preliminary study[J]. Int Clin Fsychopharmacol, 2009, 24 ( 5 ) : 265-269.
  • 8Muscatello M R, Bruno A, Pandolfo G, et al.Effect of aripiprazole augmentation of serotonin reuptake inhibitors or clomipramine in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study[Jl.J Clin Psychopharmacol, 2011, 31 ( 2 ) : 174-179.
  • 9Delle Chiaie R, Searciglia P, Pasquini M, et al.Aripiprazole augmentation in patients with resistant obsessive compulsive disorder: a pilot study[J]. Clin Pract Epidemiol Ment Health, 2011, 7 ( 45 ) : 107-111.
  • 10王会格,王旭.不孕症患者认知行为护理干预对抑郁的影响评价.中国保健营养(上旬刊),2014,24(2):950-951.

引证文献5

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部